| |
Latest 10 SEC filings (by transaction date) for IMUX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 6/24 | Mar 4/24 | Howson Tamar D | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 64,959 | |
Mar 6/24 | Mar 4/24 | Howson Tamar D | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -10,000 | |
Mar 6/24 | Mar 4/24 | Howson Tamar D | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -10,000 | |
Mar 6/24 | Mar 4/24 | Howson Tamar D | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -15,000 | |
Mar 6/24 | Mar 4/24 | Howson Tamar D | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -9,986 | |
Mar 6/24 | Mar 4/24 | Howson Tamar D | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -19,973 | |
Mar 6/24 | Mar 4/24 | Nash Duane | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -10,000 | |
Mar 6/24 | Mar 4/24 | Nash Duane | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -75,000 | |
Mar 6/24 | Mar 4/24 | Nash Duane | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -10,000 | |
Mar 6/24 | Mar 4/24 | Nash Duane | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -90,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for IMUX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 6/24 | Mar 4/24 | Howson Tamar D | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 64,959 | |
Mar 6/24 | Mar 4/24 | Howson Tamar D | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -10,000 | |
Mar 6/24 | Mar 4/24 | Howson Tamar D | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -10,000 | |
Mar 6/24 | Mar 4/24 | Howson Tamar D | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -15,000 | |
Mar 6/24 | Mar 4/24 | Howson Tamar D | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -9,986 | |
Mar 6/24 | Mar 4/24 | Howson Tamar D | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -19,973 | |
Mar 6/24 | Mar 4/24 | Nash Duane | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -10,000 | |
Mar 6/24 | Mar 4/24 | Nash Duane | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -75,000 | |
Mar 6/24 | Mar 4/24 | Nash Duane | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -10,000 | |
Mar 6/24 | Mar 4/24 | Nash Duane | Direct Ownership | Stock Option | D - Disposition to issuer under Rule 16b-3(e) | -90,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Cerevel Therapeutics Hold (OQ:CERE) |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |